FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102616195> ?p ?o ?g. }

• W2102616195 endingPage "7" @default.
• W2102616195 startingPage "7" @default.
• W2102616195 abstract "LY450139 (semagacestat) inhibits γ-secretase, a key enzyme for generation of amyloid β (Aβ), the peptide deposited in plaques in Alzheimer disease (AD). Previous data have shown that LY450139 lowers plasma Aβ, but has no clear effect on Aβ1-40 or Aβ1-42 levels in cerebrospinal fluid (CSF). By using targeted proteomics techniques, we recently identified several shorter Aβ isoforms, such as Aβ1-16, that in experimental settings increase during γ-secretase inhibitor treatment, and thus may serve as sensitive biochemical indices of the treatment effect. Here, we test the hypothesis that these shorter Aβ isoforms may be biomarkers of γ-secretase inhibitor treatment in clinical trials. In a phase II clinical trial, 35 individuals with mild to moderate AD were randomized to placebo (n = 10) or LY450139 (100 mg (n = 15) or 140 mg (n = 10)) and underwent lumbar puncture at baseline and after 14 weeks of treatment. The CSF Aβ isoform pattern was analyzed with immunoprecipitation combined with MALDI-TOF mass spectrometry. The CSF levels of Aβ1-14, Aβ1-15, and Aβ1-16 showed a dose-dependent increase by 57% and 74%, 21% and 35%, and 30% and 67%, respectively in the 100-mg and 140-mg treatment groups. Aβ1-40 and Aβ1-42 were unaffected by treatment. CSF Aβ1-14, Aβ1-15, and Aβ1-16 increase during γ-secretase inhibitor treatment in AD, even at doses that do not affect Aβ1-42 or Aβ1-40, probably because of increased substrate availability of the C99 APP stub (APP β-CTF) induced by γ-secretase inhibition. These Aβ isoforms may be novel sensitive biomarkers to monitor the biochemical effect in clinical trials. Clinical Trials.gov NCT00244322" @default.
• W2102616195 created "2016-06-24" @default.
• W2102616195 creator A5025313057 @default.
• W2102616195 creator A5040086950 @default.
• W2102616195 creator A5046369974 @default.
• W2102616195 creator A5057473716 @default.
• W2102616195 creator A5080609944 @default.
• W2102616195 creator A5084370208 @default.
• W2102616195 creator A5091785793 @default.
• W2102616195 date "2010-01-01" @default.
• W2102616195 modified "2023-09-25" @default.
• W2102616195 title "A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease" @default.
• W2102616195 cites W139300322 @default.
• W2102616195 cites W1480987708 @default.
• W2102616195 cites W1500435511 @default.
• W2102616195 cites W1531666134 @default.
• W2102616195 cites W1534001036 @default.
• W2102616195 cites W1554535382 @default.
• W2102616195 cites W1644122431 @default.
• W2102616195 cites W1746708220 @default.
• W2102616195 cites W1754645121 @default.
• W2102616195 cites W1867806574 @default.
• W2102616195 cites W1976115853 @default.
• W2102616195 cites W1988071597 @default.
• W2102616195 cites W1993103003 @default.
• W2102616195 cites W1996317447 @default.
• W2102616195 cites W2011347889 @default.
• W2102616195 cites W2014898742 @default.
• W2102616195 cites W2036755286 @default.
• W2102616195 cites W2062283435 @default.
• W2102616195 cites W2071953900 @default.
• W2102616195 cites W2075694105 @default.
• W2102616195 cites W2077299724 @default.
• W2102616195 cites W2108537069 @default.
• W2102616195 cites W2122109494 @default.
• W2102616195 cites W2133019124 @default.
• W2102616195 cites W2156220037 @default.
• W2102616195 cites W2157152668 @default.
• W2102616195 cites W2162815565 @default.
• W2102616195 cites W2163185773 @default.
• W2102616195 cites W2171259749 @default.
• W2102616195 cites W2775777157 @default.
• W2102616195 doi "https://doi.org/10.1186/alzrt30" @default.
• W2102616195 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2876785" @default.
• W2102616195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20350302" @default.
• W2102616195 hasPublicationYear "2010" @default.
• W2102616195 type Work @default.
• W2102616195 sameAs 2102616195 @default.
• W2102616195 citedByCount "86" @default.
• W2102616195 countsByYear W21026161952012 @default.
• W2102616195 countsByYear W21026161952013 @default.
• W2102616195 countsByYear W21026161952014 @default.
• W2102616195 countsByYear W21026161952015 @default.
• W2102616195 countsByYear W21026161952016 @default.
• W2102616195 countsByYear W21026161952017 @default.
• W2102616195 countsByYear W21026161952018 @default.
• W2102616195 countsByYear W21026161952019 @default.
• W2102616195 countsByYear W21026161952020 @default.
• W2102616195 countsByYear W21026161952021 @default.
• W2102616195 countsByYear W21026161952022 @default.
• W2102616195 crossrefType "journal-article" @default.
• W2102616195 hasAuthorship W2102616195A5025313057 @default.
• W2102616195 hasAuthorship W2102616195A5040086950 @default.
• W2102616195 hasAuthorship W2102616195A5046369974 @default.
• W2102616195 hasAuthorship W2102616195A5057473716 @default.
• W2102616195 hasAuthorship W2102616195A5080609944 @default.
• W2102616195 hasAuthorship W2102616195A5084370208 @default.
• W2102616195 hasAuthorship W2102616195A5091785793 @default.
• W2102616195 hasBestOaLocation W21026161951 @default.
• W2102616195 hasConcept C104317684 @default.
• W2102616195 hasConcept C126322002 @default.
• W2102616195 hasConcept C134018914 @default.
• W2102616195 hasConcept C185592680 @default.
• W2102616195 hasConcept C2779134260 @default.
• W2102616195 hasConcept C2779651940 @default.
• W2102616195 hasConcept C31705614 @default.
• W2102616195 hasConcept C36103677 @default.
• W2102616195 hasConcept C502032728 @default.
• W2102616195 hasConcept C53345823 @default.
• W2102616195 hasConcept C55493867 @default.
• W2102616195 hasConcept C71924100 @default.
• W2102616195 hasConcept C98274493 @default.
• W2102616195 hasConceptScore W2102616195C104317684 @default.
• W2102616195 hasConceptScore W2102616195C126322002 @default.
• W2102616195 hasConceptScore W2102616195C134018914 @default.
• W2102616195 hasConceptScore W2102616195C185592680 @default.
• W2102616195 hasConceptScore W2102616195C2779134260 @default.
• W2102616195 hasConceptScore W2102616195C2779651940 @default.
• W2102616195 hasConceptScore W2102616195C31705614 @default.
• W2102616195 hasConceptScore W2102616195C36103677 @default.
• W2102616195 hasConceptScore W2102616195C502032728 @default.
• W2102616195 hasConceptScore W2102616195C53345823 @default.
• W2102616195 hasConceptScore W2102616195C55493867 @default.
• W2102616195 hasConceptScore W2102616195C71924100 @default.
• W2102616195 hasConceptScore W2102616195C98274493 @default.
• W2102616195 hasIssue "2" @default.
• W2102616195 hasLocation W21026161951 @default.
• W2102616195 hasLocation W21026161952 @default.

• next